Cargando…
Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review
INTRODUCTION: Venous thromboembolism (VTE) is a leading cause of morbidity and mortality globally. The direct oral anticoagulants, including rivaroxaban, are relatively novel therapeutic options in the treatment and prevention of VTE. There is a conflicting and inconclusive evidence surrounding the...
Autores principales: | Alalawneh, Majdoleen, Awaisu, Ahmed, Rachid, Ousama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734246/ https://www.ncbi.nlm.nih.gov/pubmed/36201149 http://dx.doi.org/10.1007/s40262-022-01160-z |
Ejemplares similares
-
Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data
por: Alalawneh, Majdoleen, et al.
Publicado: (2023) -
Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban
por: Liu, Xiao-Qin, et al.
Publicado: (2023) -
Transferability of Published Population Pharmacokinetic Models for Apixaban and Rivaroxaban to Subjects with Obesity Treated for Venous Thromboembolism: A Systematic Review and External Evaluations
por: Leven, Cyril, et al.
Publicado: (2023) -
Pharmacokinetic Properties of Rivaroxaban in Healthy Human Subjects
por: Bratsos, Sosipatros
Publicado: (2019) -
Impact of COVID-19 Pandemic on Healthcare-Associated Infections: A Systematic Review and Meta-Analysis
por: Abubakar, Usman, et al.
Publicado: (2023)